Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
Engineered viruses and gene therapy halt tumor growth and extend survival in mice

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

Mass General Brigham researchers share cancer research discoveries at ASCO 2025

Mass General Brigham researchers share cancer research discoveries at ASCO 2025

New plant-derived therapy shows promise for cancer pain relief

New plant-derived therapy shows promise for cancer pain relief

New blood test detects HPV-linked head and neck cancer with unmatched accuracy

New blood test detects HPV-linked head and neck cancer with unmatched accuracy

Shorter radiation treatment after surgery found safe for prostate cancer patients

Shorter radiation treatment after surgery found safe for prostate cancer patients

Cancer-related fatigue and depression found to limit recreational activities in survivors

Cancer-related fatigue and depression found to limit recreational activities in survivors

Predictive model could improve treatment decisions for advanced pancreatic cancer patients

Predictive model could improve treatment decisions for advanced pancreatic cancer patients

New $224 million proton therapy center coming to Penn Presbyterian

New $224 million proton therapy center coming to Penn Presbyterian

MD Anderson researchers present promising clinical trial results at AACR 2025

MD Anderson researchers present promising clinical trial results at AACR 2025

Prostate cancer diagnosis is not a death sentence, study says

Prostate cancer diagnosis is not a death sentence, study says

Novel technology for in situ irradiation of tumors

Novel technology for in situ irradiation of tumors

Hyperbaric oxygen therapy brings long-term relief after cancer radiation

Hyperbaric oxygen therapy brings long-term relief after cancer radiation

Study: Rural cancer patients cross state lines for specialized care

Study: Rural cancer patients cross state lines for specialized care

Triple therapy reduces tumor burden and improves survival in glioblastoma models

Triple therapy reduces tumor burden and improves survival in glioblastoma models

New state-of-the-art cancer treatment center opens in Newport Beach

New state-of-the-art cancer treatment center opens in Newport Beach

Study reveals progressive breast shrinkage after breast-conserving therapy

Study reveals progressive breast shrinkage after breast-conserving therapy

Researchers unlock key process for regenerating intestinal cells after injury

Researchers unlock key process for regenerating intestinal cells after injury

New trial aims to make rectal cancer more responsive to radiation

New trial aims to make rectal cancer more responsive to radiation

Breast cancer survivors face accelerated aging tied to tumors and treatment

Breast cancer survivors face accelerated aging tied to tumors and treatment

Breast cancer treatments contribute to aging acceleration in survivors

Breast cancer treatments contribute to aging acceleration in survivors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.